The Broad Institute (Cambridge, Massachusetts, USA) and Fluidigm Corporation (South San Francisco, California, USA) have announced the launch of a research centre dedicated to accelerating the development of research methods and discoveries in mammalian single-cell genomics.
The Broad Institute (Cambridge, Massachusetts, USA) and Fluidigm Corporation (South San Francisco, California, USA) have announced the launch of a research centre dedicated to accelerating the development of research methods and discoveries in mammalian single-cell genomics.
The Single-Cell Genomics Centre will be based at the Broad Institute and will feature a complete suite of Fluidigm single-cell tools, protocols and technologies. The centre evolved out of ongoing collaborations between the Broad Institute and Fluidigm. The centre plans to develop novel single-cell, microfluidic approaches for gene expression profiling, RNA/DNA sequencing and epigenetic analysis. The aim of these efforts is to make single-cell research accessible to the greater scientific community by developing new workflows, reagents, bioinformatics tools and data sets. These advances will allow a deeper exploration of the underlying causes of many diseases, including the progression of individual cancers.
Gajus Worthington, President and Chief Executive Officer of Fluidigm, said, "The cell is the fundamental unit of life, and through greater understanding of it, researchers can make breakthroughs in large and important fields, such as cancer diagnosis and therapy, stem cell biology, vaccine development, and even the mounting battle against drug-resistant bacteria. We expect this centre to inspire, enable and accelerate efforts in the emerging field of single-cell research."
Ken Livak, PhD, Fluidigm Senior Scientific Fellow, who will act as the Alliance Manager at the Broad Institute, overseeing research projects between the centre and project partner, commented, "Our intent is to establish the centre as a focal point to enhance collaboration and accelerate the science, applications, methods and discoveries in single-cell genomics research. Our efforts with the Broad Institute in forming a centre that specifically focuses on single-cell research represent a big step forward for this emerging area of biological research."
For more information please visit ref="http://www.fluidigm.com">www.fluidigm.com
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.